Effects of highly purified anthraquinoid compounds from Aloe vera on sensitive and multidrug resistant leukemia cells

被引:7
作者
Grimaudo, S
Tolomeo, M
Gancitano, RA
DAlessandro, N
Aiello, E
机构
[1] UNIV PALERMO POLICLIN,IST FARMACOL,I-90127 PALERMO,ITALY
[2] UNIV PARMA,IST FARMACOCHIM,I-90127 PALERMO,ITALY
[3] UNIV PARMA,CATTEDRA EMATOL,I-90127 PALERMO,ITALY
关键词
aloe emodine; antineoplastic drugs; multidrug resistance;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Folk medicine has attributed antitumor properties to preparations from Aloe vera. We have studied the effects of five purified compounds from the plant on human K562 leukemia and on its multidrug resistant (MDR) variant, K562/R. The glycosides aloin A and B, aloesin and aloeresin were devoid of antitumor activity up to 200 mu M concentrations. Only the aglycone aloe emodin produced reproducible antitumor effects, which, interestingly, were more pronounced in the MDR, P-glycoprotein overexpressing, cell line. Its IC50 was in fact 29 mu M in K562 and 10.5 mu M in K562/R. Aloe emodine caused mainly cytostasis and accumulation of the cells in the S and G(2)-M phases of the cell cycle during the first 48 h of treatment. Thereafter, massive cell death ensued. Research on the antitumor activity of compounds extracted from Aloe vera probably deserves continuation.
引用
收藏
页码:341 / 343
页数:3
相关论文
共 16 条
[1]
INVITRO VIRUCIDAL ACTIVITY OF SELECTED ANTHRAQUINONES AND ANTHRAQUINONE DERIVATIVES [J].
ANDERSEN, DO ;
WEBER, ND ;
WOOD, SG ;
HUGHES, BG ;
MURRAY, BK ;
NORTH, JA .
ANTIVIRAL RESEARCH, 1991, 16 (02) :185-196
[2]
BERNARD DL, 1992, ANTIVIR RES, V17, P63
[3]
BOUCHEY GD, 1969, Q J CRUDE DRUG RES, V9, P1445
[4]
BUTTINER M, 1973, Revista Latinoamericana de Quimica, V4, P8
[5]
FUJITA K, 1976, BIOCHEM PHARMACOL, V25, P205
[6]
GJERSTAD G, 1971, Advancing Frontiers of Plant Sciences, V28, P311
[7]
PHARMACOLOGICAL STUDIES ON A PLANT LECTIN, ALOCTIN-A .1. GROWTH-INHIBITION OF MOUSE METHYLCHOLANTHRENE-INDUCED FIBRO-SARCOMA (METH-A) IN ASCITES FORM BY ALOCTIN-A [J].
IMANISHI, K ;
ISHIGURO, T ;
SAITO, H ;
SUZUKI, I .
EXPERIENTIA, 1981, 37 (11) :1186-1187
[8]
KUPCHAN SM, 1976, LLOYDIA, V39, P223
[9]
LU M, 1989, ZHONGGUO YAOKE DAXUE, V20, P155
[10]
PASZKIEWICZGADEK A, 1988, POL J PHARMACOL PHAR, V40, P183